JP2023514520A5 - - Google Patents

Info

Publication number
JP2023514520A5
JP2023514520A5 JP2022546665A JP2022546665A JP2023514520A5 JP 2023514520 A5 JP2023514520 A5 JP 2023514520A5 JP 2022546665 A JP2022546665 A JP 2022546665A JP 2022546665 A JP2022546665 A JP 2022546665A JP 2023514520 A5 JP2023514520 A5 JP 2023514520A5
Authority
JP
Japan
Application number
JP2022546665A
Other languages
Japanese (ja)
Other versions
JP7504209B2 (ja
JP2023514520A (ja
JPWO2021153984A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2021/001082 external-priority patent/WO2021153984A1/ko
Publication of JP2023514520A publication Critical patent/JP2023514520A/ja
Publication of JP2023514520A5 publication Critical patent/JP2023514520A5/ja
Publication of JPWO2021153984A5 publication Critical patent/JPWO2021153984A5/ja
Application granted granted Critical
Publication of JP7504209B2 publication Critical patent/JP7504209B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022546665A 2020-01-30 2021-01-27 ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体-薬物複合体 Active JP7504209B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20200011222 2020-01-30
KR10-2020-0011222 2020-01-30
PCT/KR2021/001082 WO2021153984A1 (ko) 2020-01-30 2021-01-27 벤조셀레노펜계 화합물, 이를 포함하는 약학적 조성물 및 항체-약물 결합체

Publications (4)

Publication Number Publication Date
JP2023514520A JP2023514520A (ja) 2023-04-06
JP2023514520A5 true JP2023514520A5 (https=) 2023-09-19
JPWO2021153984A5 JPWO2021153984A5 (https=) 2023-09-19
JP7504209B2 JP7504209B2 (ja) 2024-06-21

Family

ID=77079632

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020155441A Active JP7726628B2 (ja) 2020-01-30 2020-09-16 ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体-薬物複合体
JP2022546665A Active JP7504209B2 (ja) 2020-01-30 2021-01-27 ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体-薬物複合体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020155441A Active JP7726628B2 (ja) 2020-01-30 2020-09-16 ベンゾセレノフェン系化合物、これを含む薬学的組成物及び抗体-薬物複合体

Country Status (8)

Country Link
US (2) US11576896B2 (https=)
EP (1) EP4083041A4 (https=)
JP (2) JP7726628B2 (https=)
KR (2) KR102894542B1 (https=)
CN (1) CN115038699B (https=)
AU (1) AU2021212559B2 (https=)
CA (1) CA3165524C (https=)
WO (1) WO2021153984A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102894542B1 (ko) * 2020-01-30 2025-12-03 (주)에임드바이오 벤조셀레노펜계 화합물, 이를 포함하는 약학적 조성물 및 항체-약물 결합체

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
ES2244991T3 (es) 1996-03-08 2005-12-16 The Scripps Research Institute Analogosmcbi de cc-1065 y las duocarmicinas.
BRPI0617546A2 (pt) * 2005-09-26 2011-07-26 Medarex Inc conjugado de fÁrmaco-anticorpo, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula de tumor, mÉtodo para retardar ou interromper o crescimento de um tumor em um sujeito mamÍfero e composto
EP1994000B1 (en) * 2006-02-02 2017-08-23 Syntarga B.V. Water-soluble cc-1065 analogs and their conjugates
AU2007211840B2 (en) * 2006-02-03 2012-03-01 Bionomics Limited Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
TWI412367B (zh) * 2006-12-28 2013-10-21 梅達雷克斯有限責任公司 化學鏈接劑與可裂解基質以及其之綴合物
KR101418776B1 (ko) * 2011-09-28 2014-07-14 사회복지법인 삼성생명공익재단 셀레노펜-접합 방향족 화합물, 및 이의 제조 방법
WO2013048177A2 (ko) * 2011-09-28 2013-04-04 세종대학교산학협력단 셀레노펜-접합 방향족 화합물, 및 이의 제조 방법
KR101460207B1 (ko) * 2011-12-07 2014-11-11 세종대학교산학협력단 셀레노펜-접합 방향족 화합물을 포함하는 항암제
US9819889B2 (en) * 2015-08-07 2017-11-14 Omnivision Technologies, Inc. Method and system to implement a stacked chip high dynamic range image sensor
KR101775440B1 (ko) * 2015-10-07 2017-09-06 세종대학교산학협력단 벤조셀레노펜계 화합물 및 이를 포함하는 항체-약물 결합체
KR102894542B1 (ko) * 2020-01-30 2025-12-03 (주)에임드바이오 벤조셀레노펜계 화합물, 이를 포함하는 약학적 조성물 및 항체-약물 결합체

Similar Documents

Publication Publication Date Title
JP2023514520A5 (https=)
CN306395924S (https=)
CN306399244S (https=)
CN305545063S (https=)
CN305545235S (https=)
CN305553353S (https=)
CN305554300S (https=)
CN305593888S (https=)
CN305594911S (https=)
CN305600387S (https=)
CN305645148S (https=)
CN305647935S (https=)
CN305667869S (https=)
CN305678620S (https=)
CN305681768S (https=)
CN305681940S (https=)
CN305682035S (https=)
CN305683250S (https=)
CN305684362S (https=)
CN305686712S (https=)
CN305707971S (https=)
CN305710627S (https=)
CN305717149S (https=)
CN305722632S (https=)
CN305805308S (https=)